Clinical Trial Update: Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity [Phase 1]

View source ↗

Summary

Follow-up Phase 1 study evaluating a single booster of AFFITOPE PD01A for safety and clinical activity in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• AFFITOPE PD01A (PD01A)

Snippet

Sponsor: Affiris AG | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED